Taiwan Biomaterial Co., Ltd.

Taiwan Biomaterial provides the development and sale of implantable medical devices in Taiwan. It provides Foamagen, a foamagen dura substitute. Its portfolio also includes stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and nickel-titanium guidewire for guiding cerebral vascular surgery, tissue repair and regeneration products for the treatment of early osteoarthritis, and CDMO. Founded in 1921, the company is based in Zhubei, Taiwan.